AptarGroup, Inc. (ATR) key performance indicators and operating metrics (27 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Currency Guidance (Euro) | 1.18 ratio | FY2026-Q2 |
| Adjusted Diluted Earnings Per Share | 1.19 USD_per_share | FY2026-Q1 |
| Reported Effective Tax Rate | 22.40 percent | FY2026-Q1 |
| Reported Sales Year-over-Year Growth | 11.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 19.20 percent | FY2026-Q1 |
| Effective Tax Rate Adjusted Earnings* | 22.60 percent | FY2026-Q1 |
| Pharma Reported Sales Growth | 7.00 percent | FY2026-Q1 |
| Net Cash Provided by Operations | 118.69M | FY2026-Q1 |
| Reported Sales Growth - Beauty | 19.00 percent | FY2026-Q1 |
| Reported Sales Growth - Closures | 5.00 percent | FY2026-Q1 |
| Core Sales Year-Over-Year Growth | 5.00 percent | FY2025-Q4 |
| Pharma Segment Core Sales Growth | 4.00 percent | FY2025-Q4 |
| Reported Sales | 963M | FY2025-Q4 |
| Adjusted EBITDA | 191M | FY2025-Q4 |
Back to ATR overview · ATR earnings · ATR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.